Pacific Biosciences Sees FY2026 Sales $165.000M-$175.000M vs $173.371M Est

Benzinga Newsdesk www.benzinga.com Positive 76.5%

Neg 0% Neu 0% Pos 76.5%

Pacific Biosciences (NASDAQ:PACB) sees FY2026 sales of $165.000 million-$175.000 million vs $173.371 million analyst estimate.